Erogetone
Erogetone is an FDA drug label for the active ingredient ARALIA QUINQUEFOLIA, BERBERIS VULGARIS, CAUSTICUM, CONIUM MACULATUM, DAMIANA, GRAPHITES, LACHESIS MUTUS, NATRUM MURIATICUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, SEPIA manufactured by Energique, Inc. administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20220628.
Generic: ARALIA QUINQUEFOLIA, BERBERIS VULGARIS, CAUSTICUM, CONIUM MACULATUM, DAMIANA, GRAPHITES, LACHESIS MUTUS, NATRUM MURIATICUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, SEPIA
Manufacturer: Energique, Inc.
Product Type: HUMAN OTC DRUG
Route: ORAL
Dosage Form:
NDC: 44911-0552
Application:
Effective: 20220628
Active Ingredients: ACTIVE INGREDIENTS: (in each drop): 11.09% of Causticum 12X, Conium Maculatum 12X, Damiana 12X, Graphites 12X, Lachesis Mutus 12X, Natrum Muriaticum 12X, Phosphoricum Acidum 12X, Phosphorus 12X, Sepia 12X; 0.10% of Aralia Quinquefolia 3X, Berberis Vulgaris 3X.
Indications & Usage
INDICATIONS: May temporarily relieve symptoms in women such as decreased sexal desire and feelings of fatigue.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Dosage & Administration
DIRECTIONS: Adults only: 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional. If symptoms persist for more than 7 days, consult your health care professional.
Contraindications
Not available.
Warnings
WARNINGS: If pregnant or breastfeeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in a cool, dry place.
Adverse Reactions
Not available.
More from same ingredient
No related products.